Evidence map›Paper›PMID 38927572›Full record

ArticleBiomedicines2024

Luteolin-7-O-β-d-Glucuronide Attenuated Cerebral Ischemia/Reperfusion Injury: Involvement of the Blood-Brain Barrier.

Xing Fan, Jintao Song, Shuting Zhang, Lihui Lu, Fang Lin, Yu Chen, Shichang Li, Xinxin Jin, Fang Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xing FanSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Jintao SongSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Shuting ZhangSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Lihui LuSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fang LinSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Yu ChenSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.
Shichang LiSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China.
Xinxin JinExperimental Teaching Center of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.
Fang WangSchool of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China.ORCID 0000-0003-4424-3728

Funding

Liaoning Provincial Livelihood Science and Technology Plan Project 2021JH2/10300073Scientific Research Project of Education Department of Liaoning Province JYTMS20231379
6 · The paper itself

Abstract

Ischemic stroke is a common cerebrovascular disease with high mortality, high morbidity, and high disability. Cerebral ischemia/reperfusion injury seriously affects the quality of life of patients. Luteolin-7-O-β-d-glucuronide (LGU) is a major active flavonoid compound extracted from

Indexed as

blood–brain barriercerebral ischemia/reperfusioninflammationluteolin-7-O-β-D-glucuronidemiddle cerebral artery occlusion

Identifiers

PMID38927572
PMCPMC11201472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.